
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement…read on
In 2015, we pioneered a “Moneyball for biotech” approach, pooling projects and promising early-stage research from academia under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare diseases and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.
BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with three approved drugs and three additional positive Phase 3 results, making the company one of the most productive R&D engines in the industry’s history.
To learn more about our story and company culture, visit us at https://bridgebio.com
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. A sister company of BridgeBio, GondolaBio secured $300M in private financing from external investors in August 2024. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas in monogenic rare diseases. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.
What You'll Do
The Chief of Staff reports directly to the CEO of BridgeBio and GondolaBio. The primary objective of this role is to increase the leverage of the CEO, facilitate interactions and information flow across the executive leadership team, take on key cross-functional strategic initiatives, and serve as a strategic thought partner to the CEO, helping to manage and direct strategic decisions for the firm going forward.
As an extension of the CEO, this role is inherently flexible, taking a central role in projects that are of top priority for BridgeBio and GondolaBio. The person in this role will help determine the theory of how we want to manage the firm going forward. The person will have a demonstrated ability to make connections, manage conversations and negotiations with potential partners, interface with investors, and coordinate with Affiliate companies with a high degree of emotional intelligence. The person will ideate and manage strategic initiatives, organize, and interpret incoming data, evaluate, and review ongoing programs, articulate, and define strategy. The person in this role will have significant impact on BridgeBio/GondolaBio and our ability to serve patients.
The Chief of Staff should be:
Responsibilities
Where You'll Work
Who You Are
Rewarding Those Who Make the Mission Possible
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Financial Benefits:
Health & Wellbeing:
Skill Development & Career Paths:
At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states.
Salary $222,800—$274,800 USD

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.
Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.